Dr. Zigman grew up in New Jersey and performed undergraduate studies at Cornell University. He obtained a dual MD-PhD degree from the University of Chicago, and remained in Chicago to complete an Internal Medicine residency. Dr. Zigman next moved to Beth Israel Deaconess Medical Center in Boston, where he completed a fellowship in Endocrinology, Diabetes and Metabolism. It was in Boston, while working in the laboratory of Dr. Joel Elmquist, where Dr. Zigman’s interest in the hormone ghrelin first arose. Dr. Zigman is currently an Assistant Professor of Internal Medicine at the University of Texas Southwestern Medical Center at Dallas, where he is affiliated with the Division of Hypothalamic Research and the Division of Endocrinology & Metabolism. He holds a secondary appointment in the Dept. of Psychiatry and also is affiliated with the Integrative Biology Graduate Program. His clinic primarily focuses on the treatment of individuals with thyroid nodules and thyroid cancer. Dr. Zigman’s research is geared primarily toward the study of the peptide hormone ghrelin and its effects on eating behaviors and mood.
